CTOs on the Move

MacuLogix

www.maculogix.com

 
MacuLogix is the only company to leverage the science of dark adaptation to help eliminate preventable blindness caused by AMD.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.maculogix.com
  • 1801 Oberlin Road Suite 301
    Middletown, PA USA 17057
  • Phone: 717.914.4067

Executives

Name Title Contact Details

Funding

MacuLogix raised $10M on 07/18/2018
MacuLogix raised $38.7M on 03/04/2019

Similar Companies

Nuo Therapeutics

Nuo Therapeutics, Inc. (formerly Cytomedix, Inc.) is a biomedical company that develops and commercializes individualized wound care therapies that harness a patient’s innate regenerative ability to stimulate wound healing. The Company’s flagship product, Aurix is a biodynamic hematogel derived from the patient’s own platelets and plasma, which is used at the point-of-care to jumpstart the natural healing process in a broad range of chronic wounds, including diabetic foot ulcers, venous leg ulcers and pressure ulcers (bedsores).

Notal Vision

Notal Vision, makers of ForeseeHome, was founded in 2000 by ophthalmologists and medical device professionals determined to reduce vision loss associated with age-related macular degeneration (AMD).

Chinook Medical Gear

Chinook Medical Gear is a Durango, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Franz Center For Children

Franz Center For Children is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biorez

Biorez is dedicated to helping patients return to full activity sooner and safer following debilitating ligament and tendon injuries. We have developed the BioBrace™ scaffold, a new implant technology to reinforce tendon and ligament repairs and to facilitate tissue regeneration. Through our proprietary open porous architecture, and use of biomaterials, the BioBrace™ has been engineered to provide a high degree of bio-inductivity to promote rapid tissue regeneration, a biomechanical profile to reinforce repairs throughout the full healing profile, and full absorption overtime to fully restore the anatomy to its normal state. Early pre-clinical work suggests the BioBrace will deliver on the promise of a superior tissue scaffold to accelerate rehabilitation, regenerate functional tissue, and improve overall outcomes. Biorez is a VC-backed startup located in New Haven, CT.